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Abstract
Background: Medical screening detects risk factors for disease or presence of disease in otherwise well persons in
order to intervene early and reduce morbidity and mortality. During antenatal care (ANC) it is important to detect
conditions that complicate pregnancy, like gestational diabetes mellitus (GDM). Despite international and local
guidelines recommending screening for GDM during ANC, there is evidence to suggest that the practice was not
being carried out adequately. A major challenge may be lack of consensus on uniform GDM screening and
diagnostic guidelines internationally and locally.
The primary objective was to determine the magnitude of screening for GDM among women receiving ANC at the
Aga Khan Hospital, Dar es Salaam and Muhimbili National Hospital, Dar es Salaam. Secondary objectives were: to
determine the methods used by health practitioners to screen for GDM, to determine the magnitude of
undiagnosed gestational diabetes mellitus among women attending ANC and factors associated with screening for
GDM among these women.
Methods: A cross-sectional analytical study was done. Data collection was done using pre-tested questionnaires
and reviewing antenatal care records. The proportion of women attending ANC who were screened for GDM was
determined. The 75 g Oral Glucose Tolerance Test (OGTT) was offered to women who had not been screened after
education and consent.
Results: Only 107 out of 358 (29.9%) had been offered some form of GDM screening. Tests used for GDM
screening were random blood sugar (56.8%), fasting blood sugar (32.8%), HbA1C (6%) and 75 g OGTT (3.4%). The
uptake of the OGTT was 27%. Of these women the prevalence of GDM was 27.9%. Factors associated with
screening for GDM were history of big baby, history of pregnancy induced hypertension and participant awareness
of GDM (all p: < 0.05).
Conclusions: Screening for GDM among women attending ANC was lower than the World Health Organization
target. Efforts should be directed towards promoting GDM screening, increasing awareness about GDM and
developing more effective screening methods.
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Background
Medical screening identifies apparently healthy people
who have a disease or increased risk of disease [1]. The
strategy helps clinicians to detect unrecognized symptomatic and pre-symptomatic disease. Screening for conditions therefore enables early diagnosis and intervention
which improves clinical outcomes and reduces costs of
health care.
Gestational diabetes mellitus (GDM) is diabetes that is
first diagnosed in the second or third trimester of pregnancy that is not clearly either preexisting type 1 or type
2 diabetes [2]. GDM is one of the conditions which
should be screened for during antenatal care (ANC).
This is because GDM increases risk of maternal and fetal
complications during pregnancy [3] and adverse health
outcomes in the future [4].
The prevalence of GDM varies across populations, ranging from 10.4 to 25% across the world [5]. Over 90% of
cases occur in low and middle income countries [6]. Although there is a lot of literature on the prevalence, management and complications of GDM, little focus has been
put on how much GDM screening i.e. the magnitude of
GDM screening is actually done. A study done in Uganda,
Tanzania and Burkina Faso showed that health care
workers did not provide all required services during ANC
despite good attendance [7]. It is worth also noting that
guidelines for screening for GDM vary across the globe and
within countries [8]. In Tanzania the national guidelines [9]
vary from the Tanzania diabetic association [10] guidelines
and both vary from the World Health Organization
(WHO) guidelines [3]. Tests used to screen for GDM in
these national guidelines include the oral glucose tolerance
test (OGTT), random blood sugar (RBS), fasting blood
sugar (FBS) and glycated haemoglobin (HbA1C).
Lack of vigilance to screen for GDM and varying
guidelines may be responsible for poor GDM screening
practices in low resource settings as shown in Cameroon
[11]. From other studies, some factors associated with
screening for GDM include: education status/ literacy,
husband support, family support, awareness of GDM or
its risks, health care providers informing the women
about the test and help with household work [12], marital status, women’s autonomy [13], employment status
[14], private health insurance status, distance to hospital,
journey time to health facility, mode of transport and
ability to pay for the service/ financial status [15].
Given the significance of the unfavourable pregnancy
outcomes of GDM but paucity of data on how much
screening is done for the condition, this study sought to
determine the magnitude of screening for GDM among
women attending ANC at two tertiary hospitals. The
study also determined the tests used for GDM screening
during antenatal care, prevalence of undiagnosed GDM
and factors associated with screening for GDM.
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Methods
Design and study site

A cross-sectional analytic study was done at the Aga
Khan Hospital Dar es Salaam and Muhimbili National
Hospital, Dar es Salaam in Tanzania. The Aga Khan
Hospital is a not for profit, tertiary care facility and the
biggest private hospital in Tanzania. Its antenatal care
clinic attends to averagely 300 women a week. Muhimbili hospital is the national referral hospital providing
tertiary care services to referral cases and the population
surrounding it. Antenatal care attendance in this hospital averages 1000 women per week.
Participants

Total sample size was 358. Sample size was determined
using a standard formula on the basis of 22% magnitude
of screening for GDM from a study in a similar setting
[11], 20% precision, 80% power, 5% non-response rate
and type I error of 5%. Each of the 2 study sites provided
half of the total sample. Convenient, consecutive sampling was used to achieve the required sample.
The study population comprised of pregnant women
above 18 years of age, who had already received some
antenatal care and who were above the gestational age at
which screening for GDM is routinely performed. Included were pregnant women attending the antenatal
care specialist clinics, aged 18 years and above, possession of antenatal card, gestational age of 30 or more
weeks calculated using menstrual dates or earliest ultra
sound scan, and who attended a 1st or 2nd trimester
antenatal care visit at the study site. Women were excluded if they had pre-existing self-reported diagnosis of
diabetes mellitus, severe illness, mental illness, participated in another study or were taking corticosteroids,
antidepressants, diuretics or beta blockers.
Data collection

During the routine health talks all women were educated
about GDM and given details about the study. Informed,
written and signed consent was obtained from willing
participants. A mini check list confirmed eligibility of
participants.
Data collection tools were an interviewer-administered
questionnaire and data extraction sheet. Participants
were interviewed using a pre-tested, structured questionnaire in the language of choice between Kiswahili and
English. The questionnaire identified patient demographic characteristics, risk factors for GDM, socioeconomic factors associated with screening for GDM,
past obstetric and medical history and tests for glycemic
status and related information regarding screening for
GDM. Additional information including weight, height,
body mass index, blood pressure was obtained and verified from the antenatal cards, patient files and laboratory
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reports. This information was recorded on the data collection sheet. Where information from the interview and
patient records differed, the latter were used.
Women were considered screened for GDM if WHO
2013 guidelines [3], Tanzania Diabetic association guidelines [10] or Tanzania ministry of health guidelines 2017
[9] had been followed. All participants found not to have
been screened for GDM were offered the 75 g OGTT.
The glucometer SD GlucoNavii® GDH blood glucose
monitoring system and SD BIOSENSOR INC lancets
were used. This apparatus had a coefficient of variation
5% above 5.55 mmol/l and within standard deviation 4
mg/dl for readings below 5.55 mmol/l. For those with
medical insurance, the cost of the test was covered by
the insurer. Cash paying clients were offered a discounted price at the Aga Khan hospital and it was offered free of charge for those who could not afford.
Interpretation of results was according to WHO 2013
guidelines [3]. Women diagnosed with GDM or prediabetic states were informed and referred for appropriate care.
Data were collected on possible determinants of
screening for GDM which were either socio-economic
factors or risk factors of GDM. The socio-economic factors included: education status/ literacy, marital status,
employment status, women’s autonomy, private health
insurance status, distance to hospital, journey time to
health facility, mode of transport, ability to pay for the
service/ financial status, husband support, family support, obstetric history, parity, awareness of GDM or its
risks, health care providers informing the women about
the test and help with household work.
The risk factors for GDM included: glycosuria, Body
Mass Index (BMI) > 25 at time of interview, hypertension in current pregnancy, history of chronic hypertension, history of pregnancy induced hypertension (PIH),
history of GDM, history of pre-diabetic states, family
history of hypertension, family history of diabetes mellitus, history of multiple pregnancy, history of delivering a
macrosomic (≥4 kg of weight) baby, clinical or ultrasound diagnosis of large for gestational age in the ongoing pregnancy, history of excessive weight gain (≥5 kg)
since 18 years of age, race, history of pregnancy loss and
grand-multiparity (≥ 5 pregnancies).
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initially screened but were diagnosed with GDM by
OGTT in the study was the magnitude of undiagnosed
GDM. Socio-economic determinants of screening for
GDM and risk factors for GDM were evaluated for association with screening for GDM using the chi-square
test and associated p-values. Factors found to be statistically significant by chi square test were further analyzed
using logistic regression for possible association with
screening for GDM.

Results
The study period was July to September 2018. During
the study period July to September 2018, there were
2250 women who attended specialist ANC at the study
sites. As shown in Fig. 1, approximately 1500 were eligible to participate. Women who consented were interviewed. Six women were excluded. Two had overt
diabetes while four had participated in other studies.
Demographic and obstetric characteristics are summarized in Table 1. The mean age of the participants was
30.2 years (SD: 4.8; range 20–44). Most of the participants were between 20 and 30 years, accounting for
57.6% of the study population. The mean gestational age
was 34.9 weeks of gestation (SD = 3.1; range 30–42). Of
all the participants, 97.2% were black African, while 2.8%
were of Asian or of other origins.
Magnitude of screening for GDM

The overall magnitude of screening for GDM at both
hospitals was 29.9% (107 of 358). The magnitude was
21.5% (38 of 177) at Aga Khan Hospital and 38.1% at
Muhimbili National Hospital (69 of 181). Of the 251 of
women found not to have been screened for GDM only
27% (68) accepted the offered OGTT.
Tests used to screen for GDM

Of the 107 participants screened for GDM, 56.8% (66)
had done random blood sugar (RBS), 32.8% (38) fasting
blood sugar (FBS), 6% [7] HbA1C and 3.4% [3] the 75 g
Oral glucose tolerance test (OGTT).
Prevalence of undiagnosed GDM

The prevalence of undiagnosed GDM was 27.9% (19 of 68).
Factors associated with screening for GDM

Data analysis

Data was entered into Microsoft excel 2007 and cleaned.
The data was then transferred to SPSS 20 for analysis.
We defined “magnitude” of screening for GDM as the
proportion of participants attending ANC who had received any test aimed at screening for GDM. Various
tests done during screening were categorized and frequencies and percentages for each calculated and recorded. The percentage of participants who had not

As shown in Tables 2 and 3, chi square analysis revealed
factors with statistically significant association with
screening for GDM to be: awareness about GDM
(p < 0.001), health worker communication about GDM
screening (p < 0.001), partner support during ANC (p =
0.045), family support during ANC (p 0.049), history of
pregnancy induced hypertension (PIH) (p = 0.022), history of delivering macrosomic baby (p = 0.023) and history of glycosuria (p = 0.002). Logistic regression analysis
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Fig. 1 Study profile of participants attending Antenatal Care at Muhimbili National Hospital and Aga Khan Hospital Dar es Salaam in 2018

(Table 4) revealed that history of delivering a macrosomic baby (p = < 0.001 OR 2.15 95% CI: 1.12–4.10), history of PIH (p = < 0.021 OR 2.34 95% CI: 1.13–4.82) and
awareness of GDM (p = < 0.001 OR 2.79 95% CI: 1.74–
4.45) were the only 3 factors associated with screening
for GDM.

Discussion
In this study the magnitude of screening for GDM was
only 30%. This value is somewhat similar to a Cameroon
study which found the screening level at 22% [11]. Both
of these values are lower than the WHO target for a
screening strategy which is 70% of the target population
[16]. The study was done in specialist clinics in tertiary
facilities, with adequate facilities for screening. In this
study specialist clinics were considered because obstetricians were expected to be able to address the complexity
and interpretation of different guidelines and tests for
GDM better than other cadres. The low screening rate
could not be attributed to poor resources or expertise.
Another study in the region showed that health workers
omit certain practices stipulated in ANC guidelines. Inadequate screening was attributed to limited resources
and expertise in the rural settings in that study [7].

The tests used for screening for GDM in order of frequency were RBS, FBS, HbA1C and OGTT. The trend
reflects the ease of performing a particular test. Compared to the OGTT the other tests are easy to use, less
labour intensive and more accessible [17]. Random
blood sugar and HbA1C also do not require fasting [18].
Performing these tests is therefore convenient to both
the health worker and the pregnant woman [18].
Whereas the OGTT has better diagnostic accuracy than
the other tests, it is more expensive and laborious to
perform [18]. This possibly is the reason why it is performed less frequently (3.4%) than other tests. If we were
to use the generally accepted OGTT as the screening
test for GDM, the magnitude of screening of 3.4% is far
below the expected standard of care. In Uganda the uptake of the OGTT was shown to be 75.4% [5]. It would
therefore plausible for health workers to offer the OGTT
more in this setting.
The prevalence of undiagnosed GDM was 28%. Prevalence of GDM in a previous Tanzanian study also done
in an urban setting was 8.4% [19]. Just like in our study
the 75 g OGTT was used for diagnosis in that study.
Our findings may be suggestive of an increasing prevalence of GDM in Tanzanian urban areas. The prevalence
in our study is somewhat similar to 31.9% in Uganda [5],
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Table 1 Baseline demographic and clinical characteristics of
participants attending Antenatal Care at Muhimbili National
Hospital and Aga Khan Hospital Dar es Salaam in 2018
Frequency
(Total 358)

Percentage
(Total 100%)

Age a
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Table 2 Univariable analysis of socio-economic determinants of
screening for Gestational Diabetes Mellitus among women
attending antenatal clinic at Muhimbili National Hospital and
Aga Khan Hospital Dar es Salaam in 2018
Factor

Prevalence (%)

p-value

Educated > tertiary level

71.8

0.926

18–25

61

17.1

Married

82.4

0.880

26–30

135

37.9

Independent source of income

79.6

0.270

31–35

113

31.7

Autonomy

76.0

0.331

36–40

37

10.4

Medical insurance

71.2

0.412

> 40

10

2.8

Personal vehicle

27.9

0.179

Live in Ilala

26.5

0.288

Residence
Ilala

95

26.5

Having help with housework

82.7

0.886

Kinondoni

113

31.6

Partner ANC attendance

64.8

0.045

Ubungo

68

19.0

Escorted by family member to ANC

52.8

0.049

Temeke

42

11.7

Awareness of GDM

45.0

< 0.001

Kigamboni

28

7.8

Health worker communication

27.7

< 0.001

Outside Dar es salaam

12

3.4

Key: ANC Antenatal care, GDM Gestational Diabetes Mellitus

Prime Gravida

94

26.3

G2

112

31.3

G3

82

22.9

G4

45

12.6

≥ G5

25

6.9

31% in Cameroon [11] and 25.8% in south Africa [20].
These findings show a higher burden than the global
prevalence of 16% [21]. Uptake of the OGTT was 27%
which was similar to the 22% of the Cameroon study.
However the uptake varies from 75.4% found in a
Ugandan study [5] and 55.4% in a South African study
[20]. These higher uptake rates could be because in

0

2

0.6

1

20

5.6

2

66

18.4

3

114

31.8

Gravidity

Number of GDM risk factors

Table 3 Univariable analysis of risk factors for Gestational
Diabetes Mellitus among women attending Antenatal care at
Muhimbili National Hospital and Aga Khan Hospital Dar es
Salaam in 2018

4

79

22.1

Risk factor

Prevalence (%)

≥5

p-value

77

21.5

Grand multiparity

6.9

0.709

History of GDM

1.1

0.094

Number of previous ANC visits
1

10

2.8

History of PIH

9.5

0.022

2

21

5.9

Hypertension detected in current pregnancy

2.5

0.707

3

46

12.8

Pre-diabetic state

2.0

0.325

4

78

21.8

Glycosuria

3.6

0.002

5

75

20.9

BMI > 25

88.5

0.619

≥6

128

35.8

History of big baby

12.6

0.023

LGA in current pregnancy

4.5

0.903

30–31.9

66

18.4

Excessive weight gain

65.9

0.281

32–34.9

103

28.8

Family history of DM

29.6

0.671

35–37.9

114

31.9

Family history of HT

43.6

0.123

38–40.9

70

19.5

History of multiple pregnancy

3.7

0.479

≥ 41

5

1.39

History of hypertension

4.5

0.662

History of pregnancy loss

27.9

0.587

Gestational age

Key: ANC Antenatal Care, aData missing for 2 participants

Key: PIH Pregnancy Induced Hypertension, GDM Gestational Diabetes Mellitus,
ANC Antenatal care, HT Hypertension, LGA Large for Gestational Age, BMI Body
Mass Index
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Table 4 Multivariate analysis of factors associated with screening for Gestational Diabetes Mellitus among ANC attendees at
Muhimbili National Hospital and Aga Khan Hospital Dar es Salaam in 2018
Characteristic

Screened for GDM

Odds ratio (95% CI)

Yes = 107 (N/%)

No = 251 (N/%)

Yes

9 (8.4%)

4 (1.6%)

No

97 (90.7%)

247 (98.4%)

Yes

20 (18.7%)

25 (10%)

No

87 (81.3%)

226 (90%)

Yes

16 (15%)

18 (7.2%)

No

91 (85%)

233 (92.8%)

Yes

67 (62.6%)

94 (37.5%)

No

40 (37.4%)

157 (62.5%)

Yes

77 (72%)

155 (61.8%)

No

29 (27.1%)

96 (38.2%)

p-value

Glycosuria
0.96 (0.880–1.053)

0.401

2.15 (1.127–4.101)

0.020

2.34 (1.131–4.827)

0.021

2.79 (1.749–4.459)

< 0.001

0.96 (0.902–1.038)

0.360

1.57 (0.993–2.504)

0.053

1.03 (0.996–1.068)

0.087

History of delivering big baby

History of PIH

Awareness of GDM

Partner attendance of ANC

Family member attendance of ANC
Yes

65 (60.7%)

124 (49.4%)

No

42 (39.3%)

127 (50.6%)

Health worker communication about GDM tests
Yes

91 (85%)

8 (3.2%)

No

15 (14%)

219 (87.3%)

Key: PIH Pregnancy Induced Hypertension, GDM Gestational Diabetes Mellitus, ANC Antenatal care

these studies, the primary objective was to determine the
prevalence of GDM using the OGTT. In our study we
offered the OGTT as part of a secondary objective.
Factors found to be statistically significantly associated with screening were awareness about GDM, history of pregnancy induced hypertension (PIH) and
history of delivering a macrosomic baby. Awareness
of GDM in our study was 45%, which is similar to
40.3% in a multiethnic Australian study [22] but varies from 17.5% in an Indian study [23]. Similar to the
findings in our study, another study in Tamil, India
showed that knowledge of GDM promotes GDM
screening [12]. People are more inclined to accept or
do tests if they are aware about the condition and its
complications. Health literacy enables patients to access and effectively use health information [24], while
low health literacy is associated with poor health outcomes [25]. PIH is a mild form of pre-eclampsia and
eclampsia which is the leading direct cause of maternal death in Tanzania [26]. This could explain why
clinicians are more vigilant with these women. Delivering a macrosomic baby is the commonest complication of GDM in some settings. For example in a

Ugandan study, macrosomia was the only obstetric
complication associated with hyperglycemia in pregnancy [5]. This also explains the possible increased
vigilance with these women.

Conclusions
In conclusion, in this study we found a low magnitude
of screening for GDM (30%). This is inadequate compared to the recommended WHO target of 70%. A significant proportion (28%) of women with GDM had not
been diagnosed with the condition; which could account
for significant adverse pregnancy outcomes.
A majority of participants (over 75%) had attended
ANC 4 or more times by the time we evaluated them
for screening. Those many contacts with a health
worker are a missed opportunity to screen for GDM
and to provide quality, comprehensive ANC services.
A sizeable proportion of women were not aware of
GDM. This calls for wider sensitization on GDM.
Universal rather than selective screening for GDM
should be adopted in this setting given the high
prevalence of risk factors for GDM. A less cumbersome gold standard test for GDM diagnosis and
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screening needs to be developed to facilitate ease of
screening. A study of attitudes and practices of ANC
providers would dissect further why adequate screening for GDM is not conducted. Studies should be
done to determine factors associated with poor uptake
of the OGTT in this setting. Follow up studies should
be done on interventions to increase screening for
GDM.
Generalizability

This study was hospital based and urban based. Therefore the study findings may not be generalised to all
settings.
Limitations

In our study, patients were consecutively sampled. This
method of sampling could have introduced some level of
bias in our findings. However, we have no reasons to believe that manner of selecting our sample would be associated with the dependent variable of being screened or
not. The principal investigator and the research assistants were not part of the clinical teams offering ANC
services.
Observational studies, like ours are prone to social desirability phenomenon while getting responses from
study participants. However, the impact of this
phenomenon on our study was reduced for most of the
time by corroborating the participants’ responses with
data that was written on the ANC. Our study did not explore the specific laboratory methods of performing the
tests used in GDM screening. However, this could not
have affected the study results.
Our study did not explore effects of health worker
workload, knowledge and cost of test on the magnitude
of screening for GDM. However, cost for the tests was
either covered by insurance, heavily discounted or offered free of charge by the health services. All ANC was
offered by obstetricians who are assumed to have adequate knowledge and similar level of training. We have
no reason to believe that the study results could be different if these factors were explored.
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Supplementary information accompanies this paper at https://doi.org/10.
1186/s12884-020-03115-3.
Additional file 1. Questionnaire.
Additional file 2. Data extraction sheet.
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